Eli Lilly’s new Prozac Fact Sheet (image below) sent to UK physicians–but not to US physicians–states that Prozac is NOT RECOMMENDED FOR CHILDREN for any indication. For a larger view, please click on the image.
The BMJ news report (below) is included in the Congressional Record transcript of the Congressional hearing at which FDA officials were grilled about why they prevented Dr. Andrew Mosholder from delivering his analysis report of the pediatric antidepressant clinical trials. http://a257.g.akamaitech.net/7/257/2422/12jan20051100/www.access.gpo.gov/congress/house/pdf/108hrg/96099.pdf
Research at US Veterans Hospitals Nationwide Under Investigation_NYT Sun, 13 Apr 2003 Veterans returning from service in the military deserve better than the medical care that awaits them at the nation’s Veterans Affairs (VA) medical centers. The Associated Press reported on Friday, April 11, that a study shows that patients…
10 monkeys killed in botched experiment at Johns Hopkins Sat, 6 Sep 2003 To err is human, but Johns Hopkins researchers have shown a tendency to cut corners on safety and ride roughshod with experimental subjects–human and animal. [See: https://ahrp.org/infomail/0701/19.php ] This time the victims are 10 monkeys and baboons…
Associated Press: More Details about FDA Warning Strattera Associated with Suicide Thu, 29 Sep 2005 On April 26, 2004, we wrote: “The Alliance for Human Research Protection is concerned that children who are prescribed the failed antidepressant, Strattera, may be exposed to undisclosed serious risks of harm. FDA’s-approved label states:…
Israeli State Comptroller Blasts Researchers for Experimenting on Patients without Consent Tue, 26 Jul 2005 Patients the world over need adeaquate protection from overreaching physicians who use patients to test experimental drugs and procedures without their informed consent. Jacques Michel, a retired director of Hadassah Hospital in Jerusalem who also…
Randomized Controlled Trials: Evidence Biased Psychiatry By David Healy, MD MRCPsych Introduction A new drug gets introduced to the market. It has been approved after stringent scrutiny by the FDA, which requires ever more convincing evidence that it works and that its safe. The new treatment will always cost more…
